Us FDA-approved Drugs

FDA, Mirum and Pharmaceuticals

US FDA approves Mirum Pharma's genetic disorder drug

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first treatment for a rare condition that interferes with the body's ability to process cholesterol.

C&EN · 8d

FDA approves drug for neurofibromatosis

The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults and children. The drug, developed by SpringWorks Therapeutics, is the first approved for treatment of NF1 in children and adults. It will be marketed under the name Gomekli.

MarketWatch · 2d

FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease

The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first FDA-approved drug to treat CTX,

Reuters · 11d

US FDA approves SpringWorks' genetic disorder drug

The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare genetic disorder, which causes tumors to grow in the tissue that covers nerves throughout the body.

Business Insider · 2d

FDA approves Mirum treatment for cerebrotendinous xanthomatosis

The Food and Drug Administration approved Ctexli for the treatment of cerebrotendinous xanthomatosis in adults. “Ctexli is the first

2don MSN

Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...

2don MSN

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

Science Friday5d

The FDA Approves A New, Non-Opioid Painkiller

Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...

1don MSN

FDA says Ozempic shortage is over, chilling boom in off-brand versions

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

devdiscourse15h

Health Sector Shifts: From Drug Approvals to Supply Disruptions

The current state of health services highlights crucial sectors facing disruptions and developments, from US foreign aid freezes affecting disease control supply chains, to the FDA's actions on new ...

Monthly Prescribing Reference3d

FDA Approves Vimkunya to Protect Against Chikungunya Virus

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.

cnbctv183d

Cipla receives US FDA approval for Nilotinib Capsules to treat Chronic Myeloid Leukemia

Cipla has received final US FDA approval for its Nilotinib Capsules (50 mg, 150 mg, 200 mg) for the treatment of Philadelphia ...

Exclusive-US FDA asks fired scientists to return, including some reviewing Musk’s Neuralink

The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...

Investor's Business Daily on MSN1d

Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage

Hims stock dropped sharply Friday after the U.S. Food and Drug Administration said the shortage of widely-used weight-loss and diabetes drugs has been resolved. The FDA website indicated that the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results